CryoLife CE-marks tissue-engineered pulmonary heart valve:
This article was originally published in Clinica
CryoLife has CE-marked for sale in Europe its second tissue-engineered heart valve. The SynerGraft model 700 pulmonary heart valve involves the use of a porcine pulmonary heart valve that has been depopulated of its own cells, providing a collagen matrix that can be colonised with the recipient's own cells. The Atlanta, Georgia firm gained European marketing clearance for its SynerGraft model 500 aortic valve last year.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.